Advanced approaches in microbiome analysis and biomarker discovery for parkinson’s disease
Keywords:
Parkinson’s diseas, periodontal pathogens, salivary biomarkers, saliva diagnostics, oligomeric α-synuclein, heme oxygenase-1, extracellular vesicles, 16s rrna sequencing, shotgun metagenomic sequencing, real-time pcr, rt-quic, machine learningAbstract
Parkinson’s disease (PD) is a progressive neurodegenerative disorder with high early-stage misdiagnosis rates due to reliance on subjective clinical assessment. Recent research highlights the role of the “oral-gut-brain” axis, where oral dysbiosis and pathogens such as Porphyromonas gingivalis may contribute to neuroinflammation and α-synuclein aggregation. Therefore, saliva has gained attention as a non-invasive source of potential PD biomarkers. Modern diagnostic methods include metagenomic sequencing, RT-qPCR for periodontal pathogens, ELISA detection of α-synuclein and Heme Oxygenase-1 (HO-1), and ultrasensitive RT-QuIC assays. Together with multi-omics and machine learning approaches, these technologies show strong potential for early and accurate PD diagnosis.